Advertisement

AAPS PharmSciTech

, Volume 19, Issue 7, pp 2843–2850 | Cite as

Influence of Postprandial Intragastric Pressures on Drug Release from Gastroretentive Dosage Forms

  • Felix Schneider
  • Melanie Hoppe
  • Mirko Koziolek
  • Werner Weitschies
Research Article Theme: Advancements in Dissolution Testing of Oral and Non-Oral Formulations
Part of the following topical collections:
  1. Theme: Advancements in Dissolution Testing of Oral and Non-Oral Formulations

Abstract

Despite extensive research in the field of gastroretentive dosage forms, this “holy grail” of oral drug delivery yet remained an unmet goal. Especially under fasting conditions, the reproducible retention of dosage forms in the stomach seems to be an impossible task. This is why such systems are often advised to be taken together with food. But also the postprandial motility can contribute significantly to the failure of gastroretentive dosage forms. To investigate the influence of postprandial pressure conditions on drug release from such systems, we used a novel in vitro dissolution tool, the dissolution stress test device. With the aid of this device, we simulated three different intragastric pressure profiles that may occur after postprandial intake. These transit scenarios were based on recently obtained, postprandial SmartPill® data. The tested systems, Glumetza® 1000 and Madopar® HBS 125, are marketed dosage forms that are based on different approaches to achieve proper gastric retention. All three transit scenarios revealed a highly pressure-sensitive drug release behavior, for both drugs. For Madopar® HBS 125, nearly complete drug release was observed even after early occurring pressures. Glumetza® 1000 seemed to be more resistant to these, most likely due to incomplete wetting of the system. On the contrary to these findings, data from standard dissolution tests using the paddle apparatus displayed controlled drug release for both systems for about 6 h. Based on these results, it can be doubted that established gastroretentive systems stay intact over a longer period of time, even under postprandial conditions.

KEY WORDS

SmartPill gastric pressure dissolution stress test device in vitro model gastroretentive dosage forms 

Notes

Funding Information

This work has received financial support from the Innovative Medicines Initiative Joint Undertaking (http://www.imi.europa.eu) under Grant Agreement No. 115369, resources of which are composed of financial contribution from the European Union Seventh Framework Program and EFPIA companies in kind contribution, as well as from the Federal Ministry of Education and Research, Germany (FKZ 03IPT612X, InnoProfile-Transfer).

References

  1. 1.
    Lopes CM, Bettencourt C, Rossi A, Buttini F, Barata P. Overview on gastroretentive drug delivery systems for improving drug bioavailability. Int J Pharm. 2016;510(1):144–58.  https://doi.org/10.1016/j.ijpharm.2016.05.016.CrossRefPubMedGoogle Scholar
  2. 2.
    Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery systems. Expert Opin Drug Deliv. 2006;3(2):217–33.  https://doi.org/10.1517/17425247.3.2.217.CrossRefPubMedGoogle Scholar
  3. 3.
    Awasthi R, Kulkarni GT. Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand? Drug Deliv. 2016;23(2):378–94.  https://doi.org/10.3109/10717544.2014.936535.CrossRefPubMedGoogle Scholar
  4. 4.
    Koziolek M, Garbacz G, Neumann M, Weitschies W. Simulating the postprandial stomach: physiological considerations for dissolution and release testing. Mol Pharm. 2013;10:1610–22.  https://doi.org/10.1021/mp300604u.CrossRefPubMedGoogle Scholar
  5. 5.
    Malagelada JR, Go VL, Summerskill WHJ. Different gastric, pancreatic, and biliary responses to solid-liquid or homogenized meals. Dig Dis Sci. 1979;24(2):101–10.  https://doi.org/10.1007/BF01324736.CrossRefPubMedGoogle Scholar
  6. 6.
    Sauter MM, Steingoetter A, Curcic J, Treier R, Kuyumcu S, Fried M, et al. Quantification of meal induced gastric secretion and its effect on caloric emptying by magnetic resonance imaging (MRI). Gastroenterology. 2011;140:297.CrossRefGoogle Scholar
  7. 7.
    Goetze O, Treier R, Fox M, Steingoetter A, Fried M, Boesiger P, et al. The effect of gastric secretion on gastric physiology and emptying in the fasted and fed state assessed by magnetic resonance imaging. Neurogastroenterol Motil. 2009;21(7):725–e72.  https://doi.org/10.1111/j.1365-2982.2009.01293.x.CrossRefPubMedGoogle Scholar
  8. 8.
    Mudie DM, Murray K, Hoad CL, Pritchard SE, Garnett MC, Amidon GL, et al. Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state. Mol Pharm. 2014;11(9):3039–47.  https://doi.org/10.1021/mp500210c.CrossRefPubMedGoogle Scholar
  9. 9.
    Schiller C, Fröhlich CP, Giessmann T, Siegmund W, Mönnikes H, Hosten N, et al. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment Pharmacol Ther. 2005;22(10):971–9.  https://doi.org/10.1111/j.1365-2036.2005.02683.x.CrossRefPubMedGoogle Scholar
  10. 10.
    Cassilly D, Kantor S, Knight LC, Maurer AH, Fisher RS, Semler J, et al. Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil. 2008;20(4):311–9.  https://doi.org/10.1111/j.1365-2982.2007.01061.x.CrossRefPubMedGoogle Scholar
  11. 11.
    Deloose E, Janssen P, Depoortere I, Tack J. The migrating motor complex: control mechanisms and its role in health and disease. Nat Rev Gastroenterol Hepatol. 2012;9(5):271–85.  https://doi.org/10.1038/nrgastro.2012.57.CrossRefPubMedGoogle Scholar
  12. 12.
    Mojaverian P, Ferguson RK, Vlasses PH, Rocci ML, Oren A, Fix JA, et al. Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition. Gastroenterology. 1985;89(2):392–7.  https://doi.org/10.1016/0016-5085(85)90342-7.CrossRefPubMedGoogle Scholar
  13. 13.
    Waterman KC. A critical review of gastric retentive controlled drug delivery. Pharm Dev Technol. 2007;12(1):1–10.  https://doi.org/10.1080/10837450601168680.CrossRefPubMedGoogle Scholar
  14. 14.
    Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos. 1995;16(5):351–80.  https://doi.org/10.1002/bdd.2510160502.CrossRefPubMedGoogle Scholar
  15. 15.
    Garbacz G, Wedemeyer RS, Nagel S, Giessmann T, Mönnikes H, Wilson CG, et al. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses. Eur J Pharm Biopharm. 2008;70(2):421–8.  https://doi.org/10.1016/j.ejpb.2008.05.029.CrossRefPubMedGoogle Scholar
  16. 16.
    Kamba M, Seta Y, Kusai A, Ikeda M, Nishimura K. A unique dosage form to evaluate the mechanical destructive force in the gastrointestinal tract. Int J Pharm. 2000;208(1):61–70.  https://doi.org/10.1016/S0378-5173(00)00552-4.CrossRefPubMedGoogle Scholar
  17. 17.
    Koziolek M, Schneider F, Grimm M, Modeβ C, Seekamp A, Roustom T, et al. Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studies. J Control Release. 2015;220:71–8.  https://doi.org/10.1016/j.jconrel.2015.10.022.CrossRefPubMedGoogle Scholar
  18. 18.
    Garbacz G, Golke B, Wedemeyer RS, Axell M, Söderlind E, Abrahamsson B, et al. Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses. Eur J Pharm Sci. 2009;38(2):147–55.  https://doi.org/10.1016/j.ejps.2009.06.010.CrossRefPubMedGoogle Scholar
  19. 19.
    Schneider F, Grimm M, Koziolek M, Modeß C, Dokter A, Roustom T, et al. Resolving the physiological conditions in bioavailability and bioequivalence studies: comparison of fasted and fed state. Eur J Pharm Biopharm. 2016;108:214–9.  https://doi.org/10.1016/j.ejpb.2016.09.009.CrossRefPubMedGoogle Scholar
  20. 20.
    Schneider F, Beeck R, Hoppe M, Koziolek M, Weitschies W. In vitro simulation of realistic gastric pressure profiles. Eur J Pharm Sci. 2017;107:71–7.  https://doi.org/10.1016/j.ejps.2017.06.037.CrossRefPubMedGoogle Scholar
  21. 21.
    Homšek I, Parojčić J, Dačević M, Petrović L, Jovanović D. Justification of metformin hydrochloride biowaiver criteria based on bioequivalence study. Arzneimittelforschung. 2010;60(9):553–9.  https://doi.org/10.1055/s-0031-1296324. CrossRefPubMedGoogle Scholar
  22. 22.
    Adis Editorial. Metformin extended release—DepoMed. Drugs R & D. 2004;5(4):231–3.  https://doi.org/10.2165/00126839-200405040-00009.CrossRefGoogle Scholar
  23. 23.
    Hair PI, Curran MP, Keam SJ. Tramadol extended-release tablets in moderate to moderately severe chronic pain in adults. CNS Drugs. 2007;21(3):259–63.  https://doi.org/10.2165/00023210-200721030-00005. CrossRefPubMedGoogle Scholar
  24. 24.
    Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernäs H, Hussain AS, et al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm. 2004;1(1):85–96.  https://doi.org/10.1021/mp034006h.CrossRefPubMedGoogle Scholar
  25. 25.
    Erni W, Held K. The hydrodynamically balanced system: a novel principle of controlled drug release. Eur Neurol. 1987;27:21–7.  https://doi.org/10.1159/000116171.CrossRefPubMedGoogle Scholar
  26. 26.
    Mandal UK, Chatterjee B, Senjoti FG. Gastro-retentive drug delivery systems and their in vivo success: a recent update. Asian Journal of Pharmaceutical Sciences. 2016;11(5):575–84.  https://doi.org/10.1016/j.ajps.2016.04.007.CrossRefGoogle Scholar
  27. 27.
    Hatton GB, Yadav V, Basit AW, Merchant HA. Animal farm: considerations in animal gastrointestinal physiology and relevance to drug delivery in humans. J Pharm Sci. 2015;104(9):2747–76.  https://doi.org/10.1002/jps.24365.CrossRefPubMedGoogle Scholar
  28. 28.
    Ewe K, Press AG, Bollen S, Schuhn I. Gastric emptying of indigestible tablets in relation to composition and time of ingestion of meals studied by metal detector. Dig Dis Sci. 1991;36(2):146–52.  https://doi.org/10.1007/BF01300748.CrossRefPubMedGoogle Scholar
  29. 29.
    Schwartz SL, Gordi T, Hou E, Cramer M, Heritier M, Cowles VE. Clinical development of metformin extended-release tablets for type 2 diabetes: an overview. Expert Opin Drug Metab Toxicol. 2008;4(9):1235–43.  https://doi.org/10.1517/17425255.4.9.1235.CrossRefPubMedGoogle Scholar
  30. 30.
    Berner B, Cowles VE. Case studies in swelling polymeric gastric retentive tablets. Expert Opin Drug Deliv. 2006;3(4):541–8.  https://doi.org/10.1517/17425247.3.4.541.CrossRefPubMedGoogle Scholar
  31. 31.
    Nakagawa T, Kondo SI, Sasai Y, Kuzuya M. Preparation of floating drug delivery system by plasma technique. Chem Pharm Bull. 2006;54(4):514–8.  https://doi.org/10.1248/cpb.54.514.CrossRefPubMedGoogle Scholar
  32. 32.
    Aoki S, Uesugi K, Tatsuishi K, Ozawa H, Kayano M. Evaluation of the correlation between in vivo and in vitro release of phenylpropanolamine HCl from controlled-release tablets. Int J Pharm. 1992;85(1–3):65–73.  https://doi.org/10.1016/0378-5173(92)90135-O.CrossRefGoogle Scholar
  33. 33.
    Aoki S, Ando H, Tatsuishi K, Uesugi K, Ozawa H. Determination of the mechanical impact force in the in vitro dissolution test and evaluation of the correlation between in vivo and in vitro release. Int J Pharm. 1993;95(1–3):67–75.  https://doi.org/10.1016/0378-5173(93)90391-R.CrossRefGoogle Scholar
  34. 34.
    Brun R, Michalek W, Surjanhata BC, Parkman HP, Semler JR, Kuo B. Comparative analysis of phase III migrating motor complexes in stomach and small bowel using wireless motility capsule and antroduodenal manometry. Neurogastroenterol Motil. 2012;24(4):332–e165.  https://doi.org/10.1111/j.1365-2982.2011.01862.x.CrossRefPubMedGoogle Scholar
  35. 35.
    Desipio J, Friedenberg FK, Korimilli A, Richter JE, Parkman HP, Fisher RS. High-resolution solid-state manometry of the antropyloroduodenal region. Neurogastroenterol Motil. 2007;19(3):188–95.  https://doi.org/10.1111/j.1365-2982.2006.00866.x.CrossRefPubMedGoogle Scholar
  36. 36.
    Garbacz G, Cadé D, Benameur H, Weitschies W. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus. Eur J Pharm Sci. 2014;57:264–72.  https://doi.org/10.1016/j.ejps.2013.08.039.CrossRefPubMedGoogle Scholar
  37. 37.
    Koziolek M, Grimm M, Garbacz G, Kühn JP, Weitschies W. Intragastric volume changes after intake of a high-caloric, high-fat standard breakfast in healthy human subjects investigated by MRI. Mol Pharm. 2014;11(5):1632–9.  https://doi.org/10.1021/mp500022u.CrossRefPubMedGoogle Scholar
  38. 38.
    Grahnen A, Eckernäs SÅ, Collin C, Ling-Andersson A, Tiger G, Nilsson M. Comparative multiple-dose pharmacokinetics of controlled-release levodopa products. Eur Neurol. 1992;32(6):343–8.  https://doi.org/10.1159/000116858.CrossRefPubMedGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2018

Authors and Affiliations

  • Felix Schneider
    • 1
  • Melanie Hoppe
    • 1
  • Mirko Koziolek
    • 1
  • Werner Weitschies
    • 1
  1. 1.Department of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport, Institute of PharmacyUniversity of GreifswaldGreifswaldGermany

Personalised recommendations